Inventor · disambiguated record
Jon Durkin
Also filed as: DURKIN JON · DURKIN JON P
7 granted patents·5 pending applications·28 citations·filing 2002–2008
82Inventor score
Top patents by PatentIndex Score
12 records- 0183US8012944B2Method for treating cancer using IAP antisense oligomer and chemotherapeutic agentPHARMASCIENCE INC·Filed 2004·Granted Sep 6, 2011·15 cites·35 claims
- 0282US7091333B2Antisense IAP nucleobase oligomers and uses thereofAEGERA THERAPEUTICS INC·Filed 2003·Granted Aug 15, 2006·9 cites·24 claims
- 0374US7714003B2Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2007·Granted May 11, 2010·1 cites·21 claims
- 0469US7230019B2Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2002·Granted Jun 12, 2007·3 cites·5 claims
- 0563US2009042953A1IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDESAEGERA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 0663US2007032445A1Antisense IAP nucleobase oligomers and uses thereofLACASSE ERIC·Filed 2006·Application pending·0 cites
- 0759US7772260B2Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2006·Granted Aug 10, 2010·0 cites·22 claims
- 0859US7741349B2Imidazo[2, 1-b]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2006·Granted Jun 22, 2010·0 cites·6 claims
- 0958US7638497B2Antisense IAP nucleobase oligomers and uses thereofAEGERA THERAPEUTICS INC·Filed 2006·Granted Dec 29, 2009·0 cites·44 claims
- 1057US2007135371A1Antisense IAP nucleobase oligomers and uses thereofLACASSE ERIC·Filed 2006·Application pending·0 cites
- 1141US2009170845A1USE OF IMIDAZO[2,1-b]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAINAEGERA THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1240US2008293653A1Method of treating autoimmune diseasesDURKIN JON·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jon Durkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →